Amgen Inc. buy Royal Bank of Canada
Start price
07.02.24
/
50%
€281.00
Target price
07.02.25
€305.58
Performance (%)
1.26%
End price
08.02.25
€284.55
Summary
This prediction ended on 08.02.25 with a price of €284.55. The BUY prediction by Royal_Bank_of_Canada finished with a performance of 1.26%. Royal_Bank_of_Canada has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €8.32 are taken into consideration when calculating the performance. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | 3.953% | 3.953% | 33.692% |
| iShares Core DAX® | 0.365% | -0.242% | 3.831% |
| iShares Nasdaq 100 | 2.592% | 1.795% | 37.831% |
| iShares Nikkei 225® | 1.801% | 7.119% | 61.364% |
| iShares S&P 500 | 1.205% | 0.930% | 25.714% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $303.00 to $329.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten